Moreover, ACR is also used as an important monitoring indicator for the efficacy of diabetic nephropathy medications, such as RAS inhibitors and sodium-glucose cotransporter 2 (SGLT2) inhibitors (3). The gene discussed is SLC5A2; the disease is diabetic kidney disease.